Recent Headlines
Within Biotechnology
ALPCO’s Quality Management System Receives ISO 13485:2016 Certification
ALPCO announces that its quality management system recently received the distinguished ISO 13485:2016 certification from Intertek to ensure the quality, safety and efficacy of its products in the clinical diagnostics field. - October 09, 2018 - ALPCO
Columbia University Announces Formation of CuRAGE Therapeutics; Lead Candidate CR-3 Monoclonal Antibody Being Developed for the Treatment of Peripheral Artery Disease
Company to Present at NYC Invitation-Only VC Event Oct. 30 - October 06, 2018 - CuRAGE Therapeutics
Arteric Sponsors Digital Pharma East
Digital Marketing Agency Continues Support of Major Healthcare Conference - October 05, 2018 - Arteric
Epitope Diagnostics, Inc. Joins MetroConnect to Expand International Growth
Epitope Diagnostics, Inc. is pleased to announce it has been selected to take part in MetroConnect 2018, an export assistance program run by the World Trade Center San Diego (WTC) and designed to help San Diego companies accelerate their global growth. This program will allow Epitope Diagnostics... - September 23, 2018 - Epitope Diagnostics, Inc.
Hans Kaspersetz to Moderate Panel at Healthcare Marketing Summit
Veteran Digital Marketing Strategist Guides Discussion on Personalization Strategies - September 21, 2018 - Arteric
cliexa-RA Implementation in Colorado Arthritis Center: A Case Study of Quadruple Aim Impacts
cliexa® partners with the Colorado Arthritis Center to identify how screening and monitoring of Rheumatoid Arthritis patients through a customized electronic platform, cliexa-RA, impacts clinical efficiency. - September 21, 2018 - cliexa
Spherium’s Cyclatop (SP14019), Safe and Efficacious for the Treatment of Atopic Dermatitis in Adults and Infants
The results of the clinical trial Cyclatop (NCT02865356) to investigate the safety, tolerability, pharmacokinetics and efficacy of SP14019 (Cyclosporine A 5% topical spray) across all group ages, for the treatment of mild to moderate atopic dermatitis, were presented today at the EADV Congress in Paris. SP14019 showed excellent safety and acceptability profile, clinically relevant and statistically significant efficacy with respect to placebo and very low systemic exposure to Cyclosporine A. - September 15, 2018 - Spherium Biomed
Experimentica Ltd. Presents at the ISER in Belfast, Northern Ireland - XXIII Biennial Meeting of the International Society for Eye Research September 9-13, 2018 | Belfast
The XXXIII Biennial Meeting of the International Society of Eye Research takes place this year from September 9-13th in Belfast, Northern Ireland, UK. Dr Jenni J. Hakkarainen – Acting COO of Experimentica Ltd. will present an oral presentation on a metalloporphyrin superoxide dismutase mimetic and the dry-eye disease. Dr Simon Kaja – CSO of Experimentica Ltd. will chair a session and present on cellular mechanisms of reactive astrocytosis and opportunities for glioprotection. - September 08, 2018 - Experimentica Ltd
CrystalGenomics Signs Export Agreement with Apsen Farmacêutica for Acelex in Brazil
CrystalGenomics, Inc. announced today that they have signed an Export Agreement with Apsen Farmacêutica for the commercialization of Acelex® (polmacoxib) in Brazil. Under the terms of the agreement, Apsen will secure exclusive rights for the Brazilian market to sell and market Acelex... - September 05, 2018 - CrystalGenomics, Inc.
Arteric Certified as a Veeva CLM Service Partner
Expands Content Development and Management Options for Healthcare Marketers - August 31, 2018 - Arteric
Trial Runners Strengthens Its Leadership Team
Trial Runners is pleased to announce additions to their executive team as well as their leadership team as a result of a fast-paced growth year. - August 17, 2018 - Trial Runners
ALPCO to Exhibit at the AACC’s 70th Annual Scientific Meeting and Clinical Lab Expo
ALPCO will promote the expansion of its STELLUX® Chemiluminescence ELISA platform, as well as its current therapeutic drug monitoring portfolio, gastroenterology testing panel, and assay qualification program at AACC’s 70th Annual Clinical Lab Expo. - July 25, 2018 - ALPCO
ALPCO and InSphero Partner to Offer a Complete Solution to Assess Beta-cell Function in Islet Microtissue Culture Models
ALPCO and InSphero announce partnership to provide customers with a complete solution to assess beta-cell function in islet microtissue culture models. - July 24, 2018 - ALPCO
Cayman Partners with LIPID MAPS® to Support Continued Development of Key Lipidomic Research Resources
Cayman has increased its financial support of the LIPID MAPS® Lipidomics Gateway. The newly launched LIPID MAPS® website (June 2018) provides easy access to free tools and resources, including a searchable lipid structure database (with over 43,000 entries), mass spectrometry spectra prediction tools, lipid structure drawing tools, experimental protocols, systems biology pathway maps, statistical analysis tools, and a curated lipid standards database. - July 21, 2018 - Cayman Chemical Company
Leader Biomedical Introduces Spine Portfolio with Targeted Therapeutic Solutions
Leader Biomedical introduces new Spine Portfolio with the launch of three targeted therapeutic solutions Adcon® Gel, Hyalosyn™ Gel, and Vebroplast® addressing adhesions, joint mobility, and vertebral compression fractures, respectively. Adcon® Gel is a biocompatible resorbable... - July 20, 2018 - Leader Biomedical
New Assay for Immunology Research Quantifies cGAS-Produced 2’3’-cGAMP in Cells
Sensitive and direct measurement of cGAMP levels in cell lysates is now possible with Cayman’s much-anticipated 2’3’-cGAMP ELISA Kit. Developed by Cayman scientists, in conjunction with expert nucleotide scientists at Biolog Life Science Institute in Germany, this competitive... - July 20, 2018 - Cayman Chemical Company
Minus K Technology Announces Sixth U.S. Educational Giveaway
Celebrating its 25th year in business Minus K Technology, Inc. is giving away $20,000* worth of patented vibration isolators to colleges within the United States. - July 18, 2018 - Minus K Technology Inc.
Medical Marketing and Media Names Arteric an Agency to Watch
Healthcare Digital Marketing Agency Recognized for Award-Winning, Ground-Breaking Work. - July 17, 2018 - Arteric
ALPCO Releases STELLUX® Chemi Active GLP-1 (7-36) Amide ELISA to Accurately Quantify Fasted Levels
ALPCO, a leading producer of research and clinical immunoassays, recently announced the launch of its STELLUX® Chemi Active GLP-1 (7-36) amide ELISA. The chemiluminescence ELISA features increased sensitivity to accurately quantify active GLP-1 (7-36) amide levels as low as 1.5 pg/mL with a 25... - July 17, 2018 - ALPCO
NuvOx Pharma Receives $2M SBIR Grant for Pancreatic Cancer Diagnostic Development
Evan Unger, MD, President and CEO of NuvOx Pharma, announced that NuvOx has received a $2M Phase II Small Business Innovation Research (SBIR) grant from the National Cancer Institute to fund the development of a new strategy to detect pancreatic cancer. The grant, 2R44CA203090-02, entitled... - July 14, 2018 - NuvOx Therapeutics
AdvantaPure® Introduces New Case Studies on Tubing, Closures and Molded Assemblies; Each Study Describes Processing Problems, Customer Goals, and Product Solutions
Three new case studies from AdvantaPure highlight fluid transfer challenges in the biopharm and pharmaceutical industries. One study explores leak-proof container systems coupled with the goal of foam reduction. Another focuses on Single-Use molded tubing assemblies in a final fill application. The third examines how a customer decided between movable totes and two styles of clean room wall pass-through systems. - July 14, 2018 - AdvantaPure
Arteric.com Continues to Garner Accolades
4 Communicator Awards Raise Total to 8 Trophies From 3 Competitions - July 10, 2018 - Arteric
ALPCO to Feature New STELLUX® Chemi Active GLP-1 (7-36) amide ELISA and Young Investigators Travel Grant Program at ADA’s 78th Scientific Sessions
ALPCO will promote its new STELLUX® Chemi Active GLP-1 (7-36) amide ELISA and Young Investigators Travel Grant Program at the American Diabetes Association’s 78th Scientific Sessions June 22-26, 2018 in Orlando, FL. - June 19, 2018 - ALPCO
APDM Wearable Technologies Awarded NIH Funding to Commercialize Novel Biofeedback System
APDM Wearable Technologies has been awarded a National Institute on Aging SBIR Phase II grant totaling $1.6 million to commercialize a real-time biofeedback system. With this funding, APDM will develop the industry's first over-ground gait biofeedback rehabilitation system utilizing both visual and... - June 19, 2018 - APDM Wearable Technologies
AdvantaPure® Completes Full BPOG Extractables Testing of Several Silicone and TPE Tubing Products; Provides Drug Manufacturers with Extensive Test Results for Comparison
Tubing manufacturer AdvantaPure announces the completion of BPOG testing on three of its tubing lines used for biopharm and pharmaceutical applications. Two styles of silicone tubing – standard and high pressure – and the company’s weldable and sealable TPE tubing now offer full BPOG test results for extractable compounds. Tests were performed by a fully-accredited, third-party test lab using a variety of analytical techniques. Results are available upon request. - June 14, 2018 - AdvantaPure
PuRxCell Names Medical Director for Taiwan
PuRxCell Offers Physicians Stem Cell Training, Protocols and Products. - June 12, 2018 - PuRxCell
Arteric to Present on Practical Applications of Artificial Intelligence (AI) in Healthcare Marketing at Digital Pharma West
Two Case Studies Illustrate the Impact of AI on Accelerating Business, and the Insights That Result. - June 08, 2018 - Arteric
Arteric.com Named Best Marketing Website and Best Professional Services Website
Latest Awards Follow Wins for Mobile Website Design. - June 06, 2018 - Arteric
MoBiTec GmbH Teams Up with ABP Biosciences, US, to Offer Superior Fluorophores at Reasonable Prices
ABP Biosciences invents, develops, and markets innovative products and technologies to scientists engaged in life sciences research, diagnostic R&D, and drug discovery. ABP specializes in the area of fluorescence labeling and detection technologies. - June 06, 2018 - MoBiTec GmbH
AdvantaPure(R) Contributes to Newly-Released Forecasting and Supply Planning Guide from BPOG; Combined Effort Aims to Improve Forecasting and Demand Planning
BPOG, the BioPhorum Operations Group, recently developed a best practices guide on forecasting and demand planning involving the biopharmaceutical industry. The guide, a collaborative effort involving biomanufacturers and suppliers, is available from BPOG’s website. It aims to help manufacturers and their vendors improve understanding and communication regarding each other’s needs. A self-assessment tool for measuring companies’ current planning processes is also available from the site. - June 01, 2018 - AdvantaPure
Mercodia Launches Unique Quality System
The immunoassay company Mercodia today announces the launch of MAQS – the Mercodia Assay Quality System. With this program, Mercodia is the first company in the field of immunoassays to set a standard for quality, ensuring customer satisfaction in all parts of its offers. Today, many... - May 17, 2018 - Mercodia AB
Virun® NutraBIOsciences® and Algarithm™ Ingredients Launch O3Omega™ Smoothies in Canada; Patent for Viruns' Spray-Dry Technology Receives Notice of Allowance in U.S.
Virun® NutraBIOsciences® and Algarithm™ Ingredients Announce O3Omega™ Smoothies Line Picked Up by Canadian Retail Giant Co-op so People Can Enjoy Plant-Based Omega 3s Every Day, the Easy Way, Notice of Allowance for Patent Covering Spray-Dried Powders Containing Non-Polar Compounds. - May 10, 2018 - VIRUN
Apostle Inc Announces Acceptance Into the StartX Accelerator Program
Apostle Inc is pleased to announce it’s been accepted into the prestigious StartX accelerator program. StartX is a renowned educational non-profit that accelerates the development of Stanford's top entrepreneurs through experiential education and collective intelligence. The acceptance rate has been between 8%-10%. - May 05, 2018 - Apostle Inc
Artificial Intelligence: Hype or Help for Healthcare Marketers?
Arteric's President Shares How AI Detects Important Signals of Audience Behavior - May 04, 2018 - Arteric
LayerBio to Present Preclinical Results for Extended Release Glaucoma Formulation at ARVO
LayerBio will present preclinical study results at the Association for Research in Vision and Ophthalmology in Honolulu, Hawaii on Monday, April 30. These results demonstrate the therapeutic potential of its novel extended-release travoprost formulation using LayerBio's proprietary PolyNet™ delivery technology. - April 27, 2018 - LayerBio, Inc.
BioDivide Ltd, a Stem Cell Company, Announces New Website Launch
The new website offers visitors rich insights into the Company’s lead stem cell product, StemPlan, and applied expertise of the therapeutic and biotechnology applications of stem cells. The website also provides a complete overview of the Company’s GMP facilities and service offerings engineered to harness the power of stem cells and regenerative medicine. - April 18, 2018 - BioDivide Limited
New Purpose-Built MaxSpec™ Standards Available for Quantitative Mass Spectrometry Analysis
Cayman Chemical has launched a new line of ready-to-use, quantitative lipid standards prepared specifically for mass spectrometry applications. This new line of MaxSpec™ analytical standards complements Cayman’s high-purity, basic research tools that researchers have been using for more... - April 18, 2018 - Cayman Chemical Company
Leveraging AI to Help Healthcare Marketers Detect Signals of Audience Behavior
Arteric's President and Chief Strategist Shares Case Studies and Insights. - April 16, 2018 - Arteric
D.L. Newslow & Associates, Inc. Announces Partnership with Savour Food Safety International, Inc.
Two food safety and management systems consulting and training powerhouses are teaming up to take you to the next level. The professional partnership between D.L. Newslow & Associates and Savour Food Safety International brings an exciting and dynamic new angle to the industry, with a fresh face of service to manufacturing companies across the U.S. and beyond. - April 11, 2018 - D.L. Newslow & Associates, Inc.
Tornado Spectral Systems Announces Feature-Packed Software Update with SpectralSoft 2.8
Security, Productivity, and Industrial Control Modules included in latest version. Tornado Spectral Systems Inc., a leading manufacturer of Raman spectrometers, released today an enhanced update of its flagship software SpectralSoft. Version 2.8 equips users with essential functionality including... - April 11, 2018 - Tornado Spectral Systems
Second Patent Awarded for AdvantaPure(R)’s AdvantaPass(R) Clean Room Wall Pass-Through System
AdvantaPure has been issued a second U.S. patent for its AdvantaPass technology. The system maintains the separation of room atmospheres to minimize contamination risks in biopharm and pharmaceutical processing. Improvements that warranted the second patent include welded wall portals, the elimination of adhesives and sealants and adjustable wall flanges. The upgrades offer users more options regarding mounting and using the system. - April 06, 2018 - AdvantaPure
Growing In Vitro Diagnostics (IVD) Market to Set New Business Opportunities for Start Up Company
Vidan Diagnostics Expected to Provide Access to Unique Tests Related to Monitoring of Diabetes and Sepis. - April 05, 2018 - Vidan Diagnostics, LLC
Apostle Inc Announces Joint Venture with Southern University of Science and Technology in the Greater China Region
Apostle Inc is pleased to announce the launch of a joint venture with Southern University of Science and Technology (SUSTech) in Shenzhen, China. The joint venture, Apostle-SUSTech Inc, will focus on the scientific and business activities in the Greater China region. David Ge, President of Apostle... - April 04, 2018 - Apostle Inc
Proteos, Inc. Honored as One of the 2018 “Best Small Business Honorees”
Proteos, Inc. has been recognized as one of the 2018 “Best Small Businesses,” an awards program presented by Michigan Celebrates Small Business. Proteos will receive the SmartZone Best Small Business of the Year Award and be honored at an awards ceremony during the fourteenth annual... - March 24, 2018 - Proteos
PuRxCell Names Medical Director for the Philippine Islands
PuRxCell Offers Physicians Stem Cell Training, Protocols and Products. Robert J. Colucci CEO of PuRxCell, LLC, a Florida based company, announced today that PuRxCell, has named Dr. Jeimylo C. de Castro as its Medical Director for the Philippine Islands and parts of Asia. “Doctor de Castro... - March 23, 2018 - PuRxCell
NCHQA's Choosing Wisely® in NC Program Significantly Reduces Unnecessary Medical Tests and Antibiotic Overuse
The Choosing Wisely® in North Carolina initiative – which aims to reduce health care waste by helping patients make smart and effective health care choices – has resulted in significant reductions in the unnecessary use of antibiotics, Pap tests and scans for osteoporosis. - March 23, 2018 - NCHQA
Leveraging AI to Uncover Signals of Audience Behavior for Healthcare Marketing
Arteric's President Shares Case Studies and Essentials for Success - March 22, 2018 - Arteric
Value Drug Scores Big in Pharmaceutical Returns
PharmaLink is the New Partner in Drug Returns Processing Value Drug, a top-rated wholesaler to independent pharmacies, announced another industry leading initiative with PharmaLink. Together they will now provide to all of their members a full array of services in the take back and processing of... - March 14, 2018 - PharmaLink
Aciont to Present Phase 1/2 Clinical Data at ARVO 2018 Annual Meeting
Aciont Inc. announced today that Dr. Kongnara Papangkorn, VP of Product Development, will be presenting clinical data of Aciont’s lead product, DSP-Visulex, from its phase 1/2 clinical trial in the treatment of noninfectious anterior uveitis (DSPV-201) at the Association for Research in... - March 10, 2018 - Aciont Inc.
ClinSearch Announces Transition in Leadership Team Welcomes Mark M. McKenzie, M.D. as Medical Director
ClinSearch, Clinical Research Specialists announces a transition in leadership at the 25-year-old clinical research site. Dr. Mark M. McKenzie is succeeding ClinSearch founder Dr. Richard A. Krause as medical director. “I have a passion for medical care and the difference it makes in the... - March 10, 2018 - Wake Research Associates